Does acarbose improve indirectly both insulin resistance and secretion in obese type 2 diabetic patients?
Our results show that a treatment with Acarbose is efficient even in diabetic patients presenting a good glucose control without any other associated treatment. By decreasing post-prandial blood glucose, acarbose improves both insulin sensitivity and secretion.
The site of the breakpoint within the M-BCR has no prognostic significance in our series.